These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38842873)

  • 21. Nomogram based on prognostic nutrition index and Chest CT imaging signs predicts lymph node metastasis in NSCLC patients.
    Chen M; Yang Y; He C; Chen L; Cheng J
    J Xray Sci Technol; 2022; 30(3):599-612. PubMed ID: 35311733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer.
    Jiang L; Jiang S; Lin Y; Yang H; Xie Z; Lin Y; Long H
    Medicine (Baltimore); 2015 Nov; 94(46):e2054. PubMed ID: 26579815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    Xie J; Pang Y; Li X; Wu X
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patients.
    Wen J; Yang Y; Liu P; Ye F; Tang H; Huang X; Zhong S; Xie X
    Breast; 2017 Jun; 33():14-22. PubMed ID: 28259045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database.
    Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J
    Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment strategies and predicting lymph node metastasis in elderly patients with papillary thyroid microcarcinoma.
    Li W; Tang Y; Li J; Han W; Wang D; Wang Y
    Medicine (Baltimore); 2021 May; 100(18):e25811. PubMed ID: 33950985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of Extent of Lymph Node Evaluation on Survival for Pathologically Lymph Node Negative Non-Small Cell Lung Cancer.
    Becker DJ; Levy BP; Gold HT; Sherman SE; Makarov DV; Schreiber D; Wisnivesky JP; Pass HI
    Am J Clin Oncol; 2018 Aug; 41(8):820-825. PubMed ID: 28301349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
    Li H; Wang Z; Yang F; Wang J
    J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
    Shang X; Liu J; Li Z; Lin J; Wang H
    BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis.
    Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C
    J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.
    He C; Ni M; Liu J; Teng X; Ke L; Matsuura Y; Okuda K; Sakairi Y; Cheng J; Yu L; Lv W; Hu J
    Transl Lung Cancer Res; 2024 Mar; 13(3):573-586. PubMed ID: 38601448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
    Park S; Cho S; Yum SW; Kim K; Jheon S
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study.
    Wang Q; Wang S; Sun Z; Cao M; Zhao X
    BMC Cancer; 2022 Jul; 22(1):801. PubMed ID: 35858848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy.
    Han H; Zhao Y; Gao Z; Zheng D; Fu F; Zhao Z; Tang Y; Xiang J; Sun Y; Hu H; Chen H
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2115-2122. PubMed ID: 31175463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
    Wang J; Chen L; Nie Y; Wu W; Yao Y
    Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes.
    Chen S; Rao H; Liu J; Geng Q; Guo J; Kong P; Li S; Liu X; Sun X; Zhan Y; Xu D
    Oncotarget; 2017 Jul; 8(28):45585-45596. PubMed ID: 28489596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer.
    Liang W; Zhang L; Jiang G; Wang Q; Liu L; Liu D; Wang Z; Zhu Z; Deng Q; Xiong X; Shao W; Shi X; He J
    J Clin Oncol; 2015 Mar; 33(8):861-9. PubMed ID: 25624438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.